Atom Investors LP Terns Pharmaceuticals, Inc. Transaction History

Atom Investors LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$4.86 - $8.19 $113,048 - $190,507	-23,261 Reduced 31.4%	50,825 $333,000
Q4 2023 Feb 14, 2024	SELL	$3.37 - $6.86 $89,749 - $182,695	-26,632 Reduced 26.44%	74,086 $480,000
Q3 2023 Nov 14, 2023	BUY	$4.7 - $8.55 $183,629 - $334,048	39,070 Added 63.38%	100,718 $506,000
Q2 2023 Aug 14, 2023	BUY	$7.35 - $13.29 $71,272 - $128,873	9,697 Added 18.67%	61,648 $539,000
Q1 2023 May 15, 2023	BUY	$7.91 - $12.0 $410,932 - $623,412	51,951 New	51,951 $615,000

167

78.3M

580K

454K

Ticker TERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,613,800
Market Cap $220M
Description
Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical t...

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

Stay updated on Atom Investors LP with notifications on news.